Roger Guedj

1.3k total citations
60 papers, 1.1k citations indexed

About

Roger Guedj is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Roger Guedj has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 27 papers in Infectious Diseases and 26 papers in Molecular Biology. Recurrent topics in Roger Guedj's work include HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (22 papers) and Fluorine in Organic Chemistry (21 papers). Roger Guedj is often cited by papers focused on HIV/AIDS drug development and treatment (27 papers), HIV Research and Treatment (22 papers) and Fluorine in Organic Chemistry (21 papers). Roger Guedj collaborates with scholars based in France, United Kingdom and United States. Roger Guedj's co-authors include Roger Condom, Audrey Farèse, Luigi A. Agrofoglio, S. R. Challand, Robert A. Earl, Edouard Suhas, Danièle Duval, Stéphane Azoulay, Nadia Patino and Cécile Vernochet and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Roger Guedj

58 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Guedj France 18 544 508 366 199 177 60 1.1k
Karl Grozinger United States 14 664 1.2× 439 0.9× 770 2.1× 619 3.1× 57 0.3× 34 1.4k
Cheng-Kon Shih United States 13 348 0.6× 337 0.7× 681 1.9× 595 3.0× 63 0.4× 16 1.1k
Noriyuki Ashida Japan 17 326 0.6× 378 0.7× 418 1.1× 252 1.3× 35 0.2× 53 976
Ayda Saldivar United States 14 314 0.6× 281 0.6× 272 0.7× 170 0.9× 18 0.1× 27 700
Joseph W. Strohbach United States 15 470 0.9× 230 0.5× 328 0.9× 246 1.2× 20 0.1× 19 850
Stacey L. McDaniel United States 7 365 0.7× 289 0.6× 447 1.2× 369 1.9× 11 0.1× 7 863
Joan A. Zugay United States 10 320 0.6× 289 0.6× 499 1.4× 399 2.0× 12 0.1× 18 812
John Milton United Kingdom 14 515 0.9× 373 0.7× 326 0.9× 213 1.1× 52 0.3× 21 1.0k
Tim H. M. Jonckers Belgium 17 412 0.8× 383 0.8× 334 0.9× 197 1.0× 16 0.1× 32 981
Charles A. Flentge United States 9 233 0.4× 212 0.4× 445 1.2× 303 1.5× 14 0.1× 14 738

Countries citing papers authored by Roger Guedj

Since Specialization
Citations

This map shows the geographic impact of Roger Guedj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Guedj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Guedj more than expected).

Fields of papers citing papers by Roger Guedj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Guedj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Guedj. The network helps show where Roger Guedj may publish in the future.

Co-authorship network of co-authors of Roger Guedj

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Guedj. A scholar is included among the top collaborators of Roger Guedj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Guedj. Roger Guedj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anquetin, Guillaume, Nassira Mahmoudi, Maud Santillana-Hayat, et al.. (2004). Synthesis of new fluoroquinolones and evaluation of their in vitro activity on Toxoplasma gondii and Plasmodium spp. Bioorganic & Medicinal Chemistry Letters. 14(11). 2773–2776. 33 indexed citations
2.
Vernochet, Cécile, Stéphane Azoulay, Danièle Duval, et al.. (2004). Human Immunodeficiency Virus Protease Inhibitors Accumulate into Cultured Human Adipocytes and Alter Expression of Adipocytokines. Journal of Biological Chemistry. 280(3). 2238–2243. 63 indexed citations
3.
Vernochet, Cécile, Stéphane Azoulay, Danièle Duval, et al.. (2003). Differential effect of HIV protease inhibitors on adipogenesis. AIDS. 17(15). 2177–2180. 22 indexed citations
4.
Azoulay, Stéphane, Marie‐Claire Nevers, Christophe Créminon, et al.. (2003). Sensitive Enzyme Immunoassay for Measuring Plasma and Intracellular Nevirapine Levels in Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy. 48(1). 104–109. 21 indexed citations
5.
Ferruà, Bernard, Christophe Créminon, Jacques Grassi, et al.. (2002). Quantification of plasma and intracellular levels of the HIV protease inhibitor ritonavir by competitive ELISA. Journal of Immunological Methods. 263(1-2). 1–9. 17 indexed citations
6.
Greiner, Jacques, et al.. (2001). Synthesis and anti-HIV activity of glucose-containing prodrugs derived from saquinavir, indinavir and nelfinavir. Carbohydrate Research. 336(3). 161–180. 24 indexed citations
7.
Duval, Danièle, et al.. (2000). Four steroidal alkaloids from the leaves of Buxus sempervirens. Phytochemistry. 54(8). 951–957. 24 indexed citations
8.
Patino, Nadia, Roger Condom, Christophe Di Giorgio, et al.. (1999). Synthesis of a New Class of HIV-1 Inhibitors. Nucleosides and Nucleotides. 18(2). 263–275. 8 indexed citations
9.
Créminon, Christophe, et al.. (1999). Quantification of Lamivudine (3TC) by Competitive Immunoassay. Nucleosides and Nucleotides. 18(4-5). 893–896. 2 indexed citations
11.
Ferruà, Bernard, R. Garraffo, Abdesslem Faraj, et al.. (1996). Quantitation of 3′-Amino-3′-deoxythymidine (AMT), a Toxic Catabolite of 3′-Azido-3′-deoxythymidine (AZT) by competitive ELISA. Journal of Immunoassay. 17(2). 175–193. 2 indexed citations
12.
Ferruà, Bernard, et al.. (1994). Measurement of the anti-HIV agent 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) by competitive ELISA. Journal of Immunological Methods. 176(1). 103–110. 9 indexed citations
13.
Agrofoglio, Luigi A., et al.. (1994). Synthesis of Three New Carbocyclic Analogues of 3′-Deoxy Purine Ribonucleosides. Nucleosides and Nucleotides. 13(5). 1147–1160. 6 indexed citations
14.
Agrofoglio, Luigi A., Edouard Suhas, Audrey Farèse, et al.. (1994). Synthesis of carbocyclic nucleosides. Tetrahedron. 50(36). 10611–10670. 340 indexed citations
15.
Agrofoglio, Luigi A., et al.. (1993). Synthesis of a new exocyclic amino carbocyclic nucleoside with potential antiviral activity.. Tetrahedron Letters. 34(39). 6271–6272. 8 indexed citations
16.
Condom, Roger, et al.. (1993). Synthesis of Some New Nucleoside Analogues as Potential Antiviral Agents. Nucleosides and Nucleotides. 12(9). 915–924. 4 indexed citations
17.
Patino, Nadia, Roger Condom, Irène Ayi, Roger Guedj, & André Aumelas. (1992). 2,5-Dioxopipérazines β-monofluorées. II. Bases d'une étude comparative des conformations en solution avec des 2,5-dioxopipérazines non-fluorées par RMN du proton et du fluor. Journal of Fluorine Chemistry. 59(1). 47–59. 2 indexed citations
18.
Guedj, Roger, et al.. (1989). Reaction of o-arylenediamines with ethyl 3-fluoro 2-ketoesters synthesis of quinoxaline derivatives. Journal of Fluorine Chemistry. 44(1). 15–23. 4 indexed citations
19.
Ourari, Ali, Roger Condom, & Roger Guedj. (1982). Méthode générale d'obtention des α-céto esters β-fluorés. Canadian Journal of Chemistry. 60(21). 2707–2710. 15 indexed citations
20.
Condom, Roger, et al.. (1978). Preparation de β-fluoro esters β-aromatiques au moyen du phenyltetraflourophosphorane. Tetrahedron Letters. 19(46). 4507–4510. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026